The Lymphomas
β Scribed by Canellos G.P., Lister T.A., Young B.
- Year
- 2006
- Tongue
- English
- Leaves
- 581
- Edition
- second edition
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Edited and written by world authorities, this text encompasses all aspects of Hodgkin's disease, non-Hodgkin's lymphomas, and related disorders. Designed to be the ''Bible'' for both clinicians and scientists who deal with lymphoma, the book is packed with useful summary tables and abundant illustrations and translates cutting-edge discoveries into state-of-the-art management guidelines. The preeminent names in research and practice bring together today's entire spectrum of knowledge β from epidemiology, classification and prognosis through diagnosis and therapy, including the latest scientific advances, such as the impact of molecular biologic and genetic discoveries and new biologic markers.
π SIMILAR VOLUMES
Edited and written by world authorities, this text encompasses all aspects of Hodgkin's disease, non-Hodgkin's lymphomas, and related disorders. Designed to be the "Bible" for both clinicians and scientists who deal with lymphoma, the book is packed with useful summary tables and abundant illustrati
Edited and written by world authorities, this text encompasses all aspects of Hodgkin's disease, non-Hodgkin's lymphomas, and related disorders. Designed to be the "Bible" for both clinicians and scientists who deal with lymphoma, the book is packed with useful summary tables and abundant illustrati
<p>Made up of two main types and several subtypes, Lymphoma is the third most common cancer diagnosed in children. Your readers are provided with essential information onΒ the Lymphomas. This book also serves as a historical survey, by providing information on the controversies surrounding its causes
The first text dedicated to peripheral T-cell lymphomas and their classification, diagnosis, and management Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoid malignancies that develop from mature T cells and natural killer (NK) cells. PTCL represents 10-15% of all cases of non-Hodgk